Open with CtrlK — press Esc to close
Novartis reported on Sept. 8 that its Phase III HARBOR trial of del-desiran missed its main goal. The drug did not produce a statistically significant improvement over placebo on video hand-opening…
Among Chinese adults who had never smoked, those with more carbon monoxide in their breath went on to develop Parkinson's disease less often than those with less, a team led from the University of…
Six computer models that estimate a person's age from proteins in the blood were run over blood samples from the same 42-patient drug trial, and all six scored the treated patients younger. Insilico…
The nerve fibers that report touch from a fingertip are among the longest cells in the body. Their working ends sit in the outer layer of the skin, and everything those ends need has to be carried…
Insulin signaling is one of the tidiest diagrams in cell biology. The hormone lands on its receptor, the receptor trips a relay of enzymes, and at the end of the chain an enzyme called Akt tells the…
Jian Li, Peng Yi and colleagues at the Joslin Diabetes Center at Harvard Medical School report that switching off a single gene turned human pancreatic duct cells into cells that make insulin, and…
Five free AI chatbots told a cooperative simulated sleep apnea patient to see a specialist in all 350 test conversations, then abandoned that advice in more than a third of conversations when the…
Two teams published large genetic studies of multiple sclerosis in Nature Genetics on Sept. 7, both using patient groups beyond the European-ancestry populations behind most of the field's data. One…
Keep your eyes on this word and notice, without moving them, what is happening at the outer limit of what you can see. A doorway to the left. Someone crossing the room at the far right. That band of…
Novartis reported on September 4, 2026 that its Phase III trial of pelacarsen, a drug designed to lower lipoprotein(a), or Lp(a), did not reduce cardiovascular events in patients who already had…
A multicenter randomized controlled trial has found that liposuction substantially reduced leg pain in women with lipoedema compared with the current standard of care, supplying the first large trial…
The FDA granted accelerated approval on Sept. 4, 2026 to Etcamah (camizestrant), made by AstraZeneca, for adults with hormone receptor-positive, HER2-negative locally advanced or metastatic breast…
Medical Disclaimer: This content is provided for general informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition, concern, symptom, or treatment decision.